Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Tsertsvadze T, Gamkrelidze A, Nasrullah M, Sharvadze L, Morgan J, Shadaker S, Gvinjilia L, Butsashvili M, Metreveli D, Kerashvili V, Ezugbaia M, Chkhartishvili N, Abutidze A, Kvaratskhelia V, Averhoff F. Tsertsvadze T, et al. Among authors: kerashvili v. BMC Infect Dis. 2020 Jan 10;20(1):30. doi: 10.1186/s12879-019-4741-5. BMC Infect Dis. 2020. PMID: 31924172 Free PMC article.
Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Tsertsvadze T, Gamkrelidze A, Chkhartishvili N, Abutidze A, Sharvadze L, Kerashvili V, Butsashvili M, Metreveli D, Gvinjilia L, Shadaker S, Nasrullah M, Adamia E, Zeuzem S, Afdhal N, Arora S, Thornton K, Skaggs B, Kuchuloria T, Lagvilava M, Sergeenko D, Averhoff F. Tsertsvadze T, et al. Among authors: kerashvili v. Clin Infect Dis. 2020 Aug 22;71(5):1263-1268. doi: 10.1093/cid/ciz956. Clin Infect Dis. 2020. PMID: 31563938 Free PMC article.
Integration of hepatitis C treatment at harm reduction centers in Georgia-Findings from a patient satisfaction survey.
Butsashvili M, Kamkamidze G, Kajaia M, Gvinjilia L, Kuchuloria T, Khonelidze I, Gogia M, Dolmazashvili E, Kerashvili V, Zakalashvili M, Shadaker S, Nasrullah M, Sonjelle S, Japaridze M, Averhoff F. Butsashvili M, et al. Among authors: kerashvili v. Int J Drug Policy. 2020 Oct;84:102893. doi: 10.1016/j.drugpo.2020.102893. Epub 2020 Jul 31. Int J Drug Policy. 2020. PMID: 32739613 Free PMC article.
Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.
Zakalashvili M, Zarkua J, Weizenegger M, Bartel J, Raabe M, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Hedskog C, Chodavarapu K, Brainard DM, McHutchison JG, Mo H, Svarovskaia E, Gish RG, Rtskhiladze I, Metreveli D. Zakalashvili M, et al. Among authors: kerashvili v. Liver Int. 2018 Mar;38(3):451-457. doi: 10.1111/liv.13540. Epub 2017 Sep 2. Liver Int. 2018. PMID: 28782185
Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia.
Zakalashvili M, Weizenegger M, Bartel J, Markowski M, Zarqua J, Kavsadze S, Kvatadze K, Basheleishvili G, Phirtskhalaishvili T, Dzagania T, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Rtskhiladze I, Metreveli D. Zakalashvili M, et al. Among authors: kerashvili v. Clin Lab. 2016 Jul 1;62(7):1347-1351. doi: 10.7754/Clin.Lab.2016.151210. Clin Lab. 2016. PMID: 28164650